The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families

By Sánchez de Abajo Ana   Hoya Miguel   Godino Javier   Furió Vicente   Tosar Alicia   Pérez-Segura Pedro   Díaz-Rubio Eduardo   Caldés Trinidad  

Familial Cancer, Vol. 4, Iss. 2, 2005-06 ,pp. : 183-186

Springer Publishing Company

Access to resources Recommend Favorite

CHEK2 1100delC mutation is frequent among Russian breast cancer patients

By Chekmariova Elena   Sokolenko Anna   Buslov Konstantin   Iyevleva Aglaya   Ulibina Yulia   Rozanov Maxim   Mitiushkina Natalia   Togo Alexandr   Matsko Dmitry   Voskresenskiy Dmitry   Chagunava Oleg   Devilee Peter   Cornelisse Cees   Semiglazov Vladimir   Imyanitov Evgeny  

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 99-102

Springer Publishing Company

Access to resources Recommend Favorite

Does breast cancer associated with CHEK2 1100delC carry characteristics of basal phenotype?

By Dede Didem   Sari Ebru   Bulut Nilufer   Altundag Kadri  

Breast Cancer Research and Treatment, Vol. 103, Iss. 3, 2007-07 ,pp. : 371-371

Springer Publishing Company

Access to resources Recommend Favorite

The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic

By Kleibl Zdenek  

Breast Cancer Research and Treatment, Vol. 90, Iss. 2, 2005-03 ,pp. : 165-167

Springer Publishing Company

Access to resources Recommend Favorite

CHEK2 1100delC is present in familial breast cancer cases of the Basque Country

By Martínez-Bouzas Cristina   Beristain Elena   Guerra Isabel   Gorostiaga Javier   Mendizabal Jose-Luis   De-Pablo Jose-Luis   García-Alegría Eva   Sanz-Parra Arantza   Tejada Maria-Isabel  

Breast Cancer Research and Treatment, Vol. 103, Iss. 1, 2007-05 ,pp. : 111-113

Springer Publishing Company

Access to resources Recommend Favorite